Modeling of Patient-Derived Xenografts in Colorectal Cancer.

about

CMScaller: an R package for consensus molecular subtyping of colorectal cancer pre-clinical models.

P2860

Q47104672-53C74443-34FE-4996-83AF-42F722130A11

P2860

Modeling of Patient-Derived Xenografts in Colorectal Cancer.

Item

http://www.wikidata.org/entity/Q38705019

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Modeling of Patient-Derived Xenografts in Colorectal Cancer.

@en

type

Item

label

Modeling of Patient-Derived Xenografts in Colorectal Cancer.

@en

prefLabel

Modeling of Patient-Derived Xenografts in Colorectal Cancer.

@en

P1476

Modeling of Patient-Derived Xenografts in Colorectal Cancer.

@en

P2093

Alexey V Sorokin

http://www.w3.org/2001/XMLSchema#string

Anastasia Katsiampoura

http://www.w3.org/2001/XMLSchema#string

Andreas Varkaris

http://www.w3.org/2001/XMLSchema#string

Bahar Salimian Rizi

http://www.w3.org/2001/XMLSchema#string

Bradley M Broom

http://www.w3.org/2001/XMLSchema#string

Christopher Bristow

http://www.w3.org/2001/XMLSchema#string

David G Menter

http://www.w3.org/2001/XMLSchema#string

Feng Tian

http://www.w3.org/2001/XMLSchema#string

Jeffrey Morris

http://www.w3.org/2001/XMLSchema#string

Ji Wu

http://www.w3.org/2001/XMLSchema#string

P2860

Amplification of the MET receptor drives resistance to anti-EGFR therapies in colorectal cancer

Patient-derived tumour xenografts as models for oncology drug development

Patient-derived tumor xenografts: transforming clinical samples into mouse models

A primary xenograft model of small-cell lung cancer reveals irreversible changes in gene expression imposed by culture in vitro

Influence of handling conditions on the establishment and propagation of head and neck cancer patient derived xenografts

KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer.

A molecularly annotated platform of patient-derived xenografts ("xenopatients") identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer.

Identification and expansion of human colon-cancer-initiating cells

Can the pharmaceutical industry reduce attrition rates?

NOD-scidIl2rg (tm1Wjl) and NOD-Rag1 (null) Il2rg (tm1Wjl) : a model for stromal cell-tumor cell interaction for human colon cancer

P304

1435-1442

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1535-7163.MCT-16-0721

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Garth Powis

P577

2017-05-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28468778

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

xenograft

P932

5562363

http://www.w3.org/2001/XMLSchema#string

Modeling of Patient-Derived Xenografts in Colorectal Cancer.

about

P2860

P2860

Modeling of Patient-Derived Xenografts in Colorectal Cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932